# Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas

> **NCT00019019** · PHASE1 · COMPLETED · sponsor: **National Institutes of Health Clinical Center (CC)** · enrollment: 70 (estimated)

## Conditions studied

- Brain and Central Nervous System Tumors
- Breast Cancer
- Kidney Cancer
- Lung Cancer
- Lymphoma
- Melanoma (Skin)
- Ovarian Cancer
- Small Intestine Cancer
- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** carboxyamidotriazole
- **DRUG:** paclitaxel

## Key facts

- **NCT ID:** NCT00019019
- **Lead sponsor:** National Institutes of Health Clinical Center (CC)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1994-10
- **Primary completion:** 2006-07
- **Final completion:** 2006-07
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2012-03-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00019019

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00019019, "Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00019019. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*